Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An update from Profound Medical ( (TSE:PRN) ) is now available.
Profound Medical Corp. has announced a partnership with Leonard Wheeler, a former NFL player and prostate cancer survivor, who will serve as a Global Ambassador for their TULSA-PRO system. This collaboration aims to increase global awareness and advocacy for the TULSA procedure, which offers a non-invasive treatment option for prostate diseases, preserving patients’ quality of life. Wheeler’s personal experience with the TULSA procedure and his commitment to educating men about this option are expected to enhance Profound Medical’s industry positioning and impact stakeholders positively by promoting a safer, effective alternative to traditional treatments.
The most recent analyst rating on (TSE:PRN) stock is a Buy with a C$12.00 price target. To see the full list of analyst forecasts on Profound Medical stock, see the TSE:PRN Stock Forecast page.
Spark’s Take on TSE:PRN Stock
According to Spark, TipRanks’ AI Analyst, TSE:PRN is a Neutral.
Profound Medical’s stock score reflects the company’s strong revenue growth and strategic potential, balanced by operational inefficiencies and financial challenges. Technical indicators suggest caution due to bearish trends, while valuation remains a concern with negative earnings. Positive earnings call sentiment and future growth prospects are encouraging, yet immediate operational improvements are necessary for sustained success.
To see Spark’s full report on TSE:PRN stock, click here.
More about Profound Medical
Profound Medical Corp. is a commercial-stage medical device company that develops and markets customizable, AI-powered, incision-free therapies for the ablation of diseased tissue. The company focuses on innovative medical solutions, particularly in the treatment of prostate diseases, using its TULSA-PRO system.
Average Trading Volume: 8,891
Technical Sentiment Signal: Sell
Current Market Cap: C$228.1M
See more data about PRN stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue